Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients
OKT3, a murine monoclonal antibody specific to the human CD3 complex, induces immunosuppression by depletion of T cells. Administration of OKT3 results in significant release of proinflammatory cytokines, such as TNFα and IL1β. Liver recipients who experience rejection within 3 weeks after transplan...
Saved in:
Main Authors: | Sasan Roayaie, Patricia A. Sheiner, Sukru Emre, Steven Guy, Myron E. Schwartz, Peter Boros, Charles M. Miller |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2000-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1080/09629350020002877 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Th1/Th2 cytokines and ICAM–1 levels post-liver transplant do not predict early rejection
by: E. Granot, et al.
Published: (2000-01-01) -
Recurrence of hepatitis C after liver transplantation is associated with increased systemic IL-10 levels
by: Patricia A. Sheiner, et al.
Published: (2001-01-01) -
Profiling the Resident and Infiltrating Monocyte/Macrophages during Rejection following Kidney Transplantation
by: Jie Wang, et al.
Published: (2020-01-01) -
The Potential of MicroRNAs as Novel Biomarkers for Transplant Rejection
by: Matthias Hamdorf, et al.
Published: (2017-01-01) -
Antibody-Mediated Rejection in Kidney Transplantation: A Review
by: Chethan Puttarajappa, et al.
Published: (2012-01-01)